Skip to main content
. 2021 Jun 25;40(31):4967–4979. doi: 10.1038/s41388-021-01792-8

Table 2.

In vivo study design.

Group 1 Group 2 Group 3
Ad-PY4-SV40-mCherry-MazF +
Ad-PY4-SV40-MazF-GFP + +
ΔAd-PY4-SV40-mCherry-MazF +
PBS +